Key result
A novel laboratory-based prediction model demonstrated superior discrimination for obstructive coronary artery disease with an AUC of 0.816 compared to the Duke Clinical Score.
Why the study?
Existing obstructive CAD prediction tools were derived in Caucasian cohorts with unknown performance in China, and mostly rely on non-laboratory variables.
Does a novel laboratory-based model improve the prediction of obstructive CAD compared to traditional clinical scores in Chinese inpatients with suspected stable chest pain?
Cohort (n=8,963)
Yes
Does a novel laboratory-based model improve the prediction of obstructive CAD compared to traditional clinical scores in Chinese inpatients with suspected stable chest pain?
Answers are grounded in this paper and cite their sources.
A novel laboratory-based prediction model significantly improved risk stratification for obstructive CAD in Chinese patients with suspected stable chest pain compared to traditional clinical scores.
Commonly used tools to assess the probability of obstructive-coronary artery disease (CAD) were derived based on Caucasian cohorts, with their performance in China is still unknown. Furthermore, most were established based on non-laboratory variables, contributing to the limited predictive ability to some extent. Thus, we developed and internally validated a laboratory-based model with data from a Chinese cohort of 8963 inpatients, with suspected stable chest pain, referred to catheter-based coronary angiography (CAG) from September 2007 to April 2019, and then compared the present model's performance with the four most commonly used prediction tools, Coronary Artery Disease Consortium 1/2 Score (CAD1/2), Duke clinical score (DCS), and Diamond-Forrester score (DF). The final model was developed by random forest method, including 8 predictors derived from 70 variables. Five-fold cross-validation was performed to evaluate the model's prediction accuracy. In the external validation set, the present model showed a superior area under the receiver-operating curve (0.816), followed by DCS (0.66), CAD2 (0.61), CAD1 (0.59) and at last DF (0.58), respectively. Furthermore, the present model correctly classified 74.4% of obstructive-CAD patients as high-risk, and correctly classified more than one third of non-obstructive-CAD patients as low-risk. The present model's net reclassification improvement (NRI) showed a significant positive reclassification over CAD1 (NRI = 0.60, P < 0.001), DF (NRI = 0.59, P < 0.001), CAD2 (NRI = 0.57, P < 0.001), and DCS (NRI = 0.43, P < 0.001). Decision curve analysis demonstrated that the present model provided a larger net benefit compared with CAD1/2, DCS, and DF. In conclusion, the novel model, using 8 laboratory and non-laboratory variables, performed well in risk stratifying patients with suspected chest pain regarding the presence of obstructive-CAD in the present Chinese cohort.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2020) conducted a cohort in Suspected stable chest pain (n=8,963). Novel laboratory-based prediction model vs. CAD Consortium 1/2 Score, Duke Clinical Score, and Diamond-Forrester Score was evaluated on Area under the receiver-operating curve (AUC) for predicting obstructive CAD in the external validation set (NRI 0.60, p=<0.001). A novel laboratory-based prediction model demonstrated superior discrimination for obstructive coronary artery disease with an AUC of 0.816 compared to the Duke Clinical Score.
Synapse has enriched 10 related papers. Consider them for comparative context: